David Shaw’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
3,081,407
-230,194
-7% -$716K 0.01% 1766
2026
Q1
$7.55M Sell
3,311,601
-247,004
-7% -$569K ﹤0.01% 1854
2025
Q4
$9.96M Buy
3,558,605
+1,238,621
+53% +$4.43M 0.01% 1762
2025
Q3
$11.1M Buy
2,319,984
+890,921
+62% +$5.67M 0.01% 1595
2025
Q2
$13M Buy
1,429,063
+616,830
+76% +$4.55M 0.01% 1305
2025
Q1
$7.33M Buy
812,233
+148,515
+22% +$1.57M 0.01% 1627
2024
Q4
$8.67M Sell
663,718
-78,671
-11% -$1.05M 0.01% 1595
2024
Q3
$11.6M Sell
742,389
-382,923
-34% -$5.8M 0.01% 1319
2024
Q2
$15.2M Sell
1,125,312
-429,868
-28% -$8.8M 0.01% 1064
2024
Q1
$43.1M Sell
1,555,180
-149,694
-9% -$3.32M 0.04% 540
2023
Q4
$32.9M Buy
1,704,874
+139,088
+9% +$2.52M 0.03% 644
2023
Q3
$25.3M Buy
1,565,786
+229,411
+17% +$4.07M 0.03% 721
2023
Q2
$25.4M Buy
1,336,375
+445,351
+50% +$7.94M 0.03% 749
2023
Q1
$13M Buy
891,024
+490,127
+122% +$8.78M 0.01% 1176
2022
Q4
$7.83M Buy
400,897
+88,409
+28% +$1.72M 0.01% 1667
2022
Q3
$7.53M Sell
312,488
-434,493
-58% -$13.4M 0.01% 1631
2022
Q2
$23.5M Sell
746,981
-744,524
-50% -$27M 0.03% 767
2022
Q1
$65.7M Sell
1,491,505
-187,686
-11% -$8.06M 0.06% 379
2021
Q4
$73M Buy
1,679,191
+107,084
+7% +$4.2M 0.06% 384
2021
Q3
$49.2M Sell
1,572,107
-524,030
-25% -$20.6M 0.04% 541
2021
Q2
$88.7M Buy
2,096,137
+742,378
+55% +$28.9M 0.08% 307
2021
Q1
$50.9M Buy
1,353,759
+643,214
+91% +$20.1M 0.05% 485
2020
Q4
$19.2M Sell
710,545
-182,761
-20% -$4.7M 0.02% 979
2020
Q3
$22.4M Buy
893,306
+675,165
+310% +$9.85M 0.02% 771
2020
Q2
$1.66M Sell
218,141
-254,225
-54% -$1.86M ﹤0.01% 2551
2020
Q1
$4.32M Buy
472,366
+255,568
+118% +$1.54M 0.01% 1572
2019
Q4
$1.12M Sell
216,798
-609,776
-74% -$3.92M ﹤0.01% 2901
2019
Q3
$4.8M Buy
826,574
+799,603
+2,965% +$3.59M 0.01% 1679
2019
Q2
$86K Sell
26,971
-23,056
-46% -$78.6K ﹤0.01% 3557
2019
Q1
$205K Buy
50,027
+16,322
+48% +$103K ﹤0.01% 3396
2018
Q4
$213K Sell
33,705
-202,196
-86% -$2.1M ﹤0.01% 3516
2018
Q3
$3.9M Sell
235,901
-311,942
-57% -$5.3M ﹤0.01% 1732
2018
Q2
$9.15M Sell
547,843
-225,209
-29% -$3.65M 0.01% 1131
2018
Q1
$12M Sell
773,052
-174,255
-18% -$3.11M 0.02% 904
2017
Q4
$17.9M Buy
947,307
+446,967
+89% +$9.91M 0.02% 738
2017
Q3
$14.6M Buy
500,340
+164,159
+49% +$4.85M 0.02% 739
2017
Q2
$10.8M Sell
336,181
-240,799
-42% -$7.9M 0.02% 863
2017
Q1
$20M Sell
576,980
-77,235
-12% -$2.76M 0.04% 579
2016
Q4
$23.1M Buy
654,215
+589,100
+905% +$19.9M 0.04% 570
2016
Q3
$2.26M Sell
65,115
-20,776
-24% -$727K ﹤0.01% 1835
2016
Q2
$3.21M Sell
85,891
-19,169
-18% -$720K 0.01% 1589
2016
Q1
$4.25M Buy
105,060
+72,788
+226% +$2.71M 0.01% 1385
2015
Q4
$1.16M Buy
+32,272
New +$1.17M ﹤0.01% 2538
2015
Q3
Sell
-30,016
Closed -$1.02M 3842
2015
Q2
$1.02M Sell
30,016
-5,777
-16% -$195K ﹤0.01% 2689
2015
Q1
$1.21M Sell
35,793
-37,206
-51% -$1.3M ﹤0.01% 2412
2014
Q4
$2.56M Buy
+72,999
New +$2.46M ﹤0.01% 2070
2014
Q3
Sell
-94,650
Closed -$3.22M 4308
2014
Q2
$3.22M Sell
94,650
-69,419
-42% -$2.38M ﹤0.01% 1934
2014
Q1
$5.75M Buy
164,069
+154,413
+1,599% +$5.45M 0.01% 1478
2013
Q4
$353K Sell
9,656
-45,917
-83% -$1.69M ﹤0.01% 3958
2013
Q3
$1.92M Buy
+55,573
New +$1.94M ﹤0.01% 2466

Other funds holding ACH

David Shaw's ACH Position: Q2 2026 in Review

David Shaw reduced its Accendra Health (ACH) stake by 7% in Q2 2026, selling an estimated $716K and leaving 3,081,407 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #1766.

David Shaw first reported a position in ACH in Q3 2013 and has held it in 50 quarters since. The position peaked at $88.7M in Q2 2021. 138 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • David Shaw held 3,081,407 shares of Accendra Health worth $10.5M as of Q2 2026.
  • David Shaw sold 230,194 Accendra Health shares in Q2 2026, an estimated $716K.
  • Accendra Health made up 0.01% of David Shaw's portfolio in Q2 2026, its #1766 holding.
  • David Shaw first reported a position in Accendra Health in Q3 2013 and has held it in 50 quarters since.
  • David Shaw's Accendra Health position peaked at $88.7M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.